{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:57:18Z","timestamp":1764784638350},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.2169\/internalmedicine.6442-20","type":"journal-article","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T22:06:23Z","timestamp":1618178783000},"page":"3273-3277","source":"Crossref","is-referenced-by-count":4,"title":["Synchronous Primary Lung Adenocarcinoma and Hepatocellular Carcinoma Successfully Treated with a Combination of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel"],"prefix":"10.2169","volume":"60","author":[{"given":"Takashi","family":"Egawa","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Masuzawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohei","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University Kitasato Institute Hospital, Japan"},{"name":"Department of Pathology, Kitasato University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsunematsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Irimie A, Achimas-Cadariu P, Burz C, Puscas E. Multiple primary malignancies--epidemiological analysis at a single tertiary institution. J Gastrointest Liver Dis 19: 69-73, 2010."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer 14: 221-230, 1961.","DOI":"10.1002\/1097-0142(196103\/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12: 20-37, 2007.","DOI":"10.1634\/theoncologist.12-1-20"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Aydiner A, Karadeniz A, Uygun K, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms. Am J Clin Oncol 23: 364-370, 2000.","DOI":"10.1097\/00000421-200008000-00011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu Z, Liu C, Guo W, Li S, Bai O. Clinical analysis of 152 cases of multiple primary malignant tumors in 15,398 patients with malignant tumors. PLoS One 10: e0125754, 2015.","DOI":"10.1371\/journal.pone.0125754"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378: 2078-2092, 2018.","DOI":"10.1056\/NEJMoa1801005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Socinski MA, Jotte RM, Cappuzzo F, et al. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med 378: 2288-2301, 2018.","DOI":"10.1056\/NEJMoa1716948"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382: 1894-1905, 2020.","DOI":"10.1056\/NEJMoa1915745"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Komatsu H, Izumi N, Tsukioka T, et al. Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancer. Surg Today 49: 343-349, 2019.","DOI":"10.1007\/s00595-018-1738-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujita S, Masago K, Takeshita J, et al. Multiple primary malignancies in patients with non-small cell lung cancer. Intern Med 54: 325-331, 2015.","DOI":"10.2169\/internalmedicine.54.2921"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Aydiner A, Karadeniz A, Uygun K, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms. Am J Clin Oncol 23: 364-370, 2000.","DOI":"10.1097\/00000421-200008000-00011"},{"key":"12","unstructured":"12. Zhang M, Kong F, Liu Y, et al. Case report synchronous primary lung cancer and hepatic cancer versus hepatic metastasis: a report of three cases and literature review. Int J Clin Exp Med 10: 16721-16726, 2017."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 7: 123-127, 2000.","DOI":"10.1097\/00125480-200007020-00007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wieczorek TJ, Pinkus JL, Glickman JN, Pinkus GS. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol 118: 911-921, 2002.","DOI":"10.1309\/KKDP-MND2-W794-P9EH"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_6442-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:41:07Z","timestamp":1715143267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_6442-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":14,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6442-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"6442-20"}}